“fda” Archives

in
Entry Author Date Location
Takeda to Buy Ariad in $5.2B Move to Build Up Cancer Drug Portfolio 01/09/17 Boston
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Biopharma Industry, Heal Thyself (Without Government Help) 01/06/17 San Diego
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
Inotek’s Glaucoma Drug Flunks in First Phase 3 Test, Shares Crumble 01/03/17 Boston
Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals 01/02/17 San Diego
Gates Foundation Sends $140M to Intarcia for HIV Version of Pump 12/29/16 Boston
FDA Rejects Cempra Antibiotic, Asks for Another Clinical Trial 12/29/16 Raleigh Durham
Biogen Sets $750,000 Initial Price For First-Ever Spinal Atrophy Drug 12/28/16 Boston
Anthera’s Shares Tumble After Cystic Fibrosis Drug Fails in Phase 3 12/28/16 San Francisco
Liver Damage, Patient Deaths Lead FDA to Halt SeaGen Leukemia Trials 12/27/16 Seattle
Top Stories of 2016 for Xconomy Boston: Editor’s Picks 12/26/16 Boston
Ionis, Biogen Make History With FDA Nod for Spine Disease Drug 12/23/16 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
Despite FDA Delay, Advocates Hopeful for New Genentech MS Drug 12/21/16 San Francisco
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
Acadia Drug Shows Early Promise in Treating Alzheimer’s Psychosis 12/20/16 San Diego
Biogen Promotes Vounatsos to CEO, Capping Scangos’s 6-Year Run 12/19/16 Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
After FDA Hold, Agios Quickly Scraps One Anemia Drug, Turns to Another 12/15/16 Boston
Goldfinch Bio Aims $55M and Cancer Strategy at Genetic Kidney Disease 12/14/16 Boston
Proteon’s Blood Vessel Drug Flunks Main Phase 3 Test, Shares Plummet 12/13/16 Boston
Asto CT Envisions Better Imaging Tech for Horses, Other Animals 12/09/16 Wisconsin
Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More 12/09/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
Senate Approves 21st Century Cures Act, Sending Bill to Obama 12/07/16 National
First Clinical Trial Done, Elysium Lands $20M for Health Supplements 12/06/16 New York
The Xconomy Immuno-Oncology Resource: A Mid-ASH T Cell Update 12/05/16 National
Eli Lilly Diabetes Drug Gets FDA OK for Reducing Heart Health Risks 12/02/16 Indiana
Boston Scientific to Buy Neovasc Heart Valve Assets in $75M Deal 12/02/16 Boston
Page 2 of 57 « previous page · next page »